Invention Grant
- Patent Title: Therapeutic nuclease compositions and methods
-
Application No.: US16229431Application Date: 2018-12-21
-
Publication No.: US11034944B2Publication Date: 2021-06-15
- Inventor: Jeffrey A. Ledbetter , Martha Hayden-Ledbetter , Keith Elkon , Xizhang Sun
- Applicant: The University of Washington
- Applicant Address: US WA Seattle
- Assignee: The University of Washington
- Current Assignee: The University of Washington
- Current Assignee Address: US WA Seattle
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K39/40
- IPC: A61K39/40 ; A61K39/00 ; C12N9/22 ; A61K47/68 ; C07K16/44 ; C07K1/00 ; A61K38/46
Abstract:
Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
Public/Granted literature
- US20190119660A1 Therapeutic Nuclease Compositions and Methods Public/Granted day:2019-04-25
Information query
